A universal respiratory syncytial virus (RSV) immunization program using Sanofi’s Beyfortus (nirsevimab) was associated with ...

Along with efficacy and safety demonstrated in clinical studies, the effectiveness of Beyfortus has been evaluated in more than 50 real-world studies, including more than 400,000 infants who were ...

Each year, the World Health Organization (WHO) partakes in World Immunization Week, a period of reflection, raising awareness, and future planning surrounding global action required to combat ...

One bill in our legislative session that was getting a lot of attention, at least with respect to written testimony, is Senate Bill 1434, Relating to Universal Immunization Funding Program. This bill ...